Viewing Study NCT01980056


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-10 @ 10:41 PM
Study NCT ID: NCT01980056
Status: COMPLETED
Last Update Posted: 2019-02-19
First Post: 2013-11-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
Sponsor: Weill Medical College of Cornell University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INT-2 or high-risk MDS View